Sample-taking isn’t Always Simple
Sampling has long relied on manual data collection. For routine blood tests, a sheet of
labels is printed and collected by a busy nurse, who then locates the patient. After a
quick visual check, the labels are peeled off and attached (hopefully) to the right tubes.
Like most manual processes, it was cost-effective—until it wasn’t.
Many errors, MSoft discovered, related to positive patient identification and incorrect
labeling—rushed caregivers just glanced at patient materials. Secondly, sample
requests could change from initial label printing (up to two days prior) until collection.
The papers were indeed a blind spot—nurses weren’t notified of deviations, such as
additional sample requests.
“In those instances are varying error rates,” explains Matt McAlister, MSoft’s managing
director. “Look at a typical hospital collecting a million samples annually through
Sample360; before integration, they averaged a 6% error rate. Looking at a million,
60,000 incorrect samples—with the wrong name or person—were rejected. When
hospitals switched to Sample360, errors dropped to 0.
“A rejected sample costs approximately £14.00. Multiplied by 60,000, that's how much
rejections cost because the samples weren’t done properly,” he says.
MSoft calculates that Sample360 saves the average health trust £560,000 annually.
Bullish about New Markets
There’s little wonder why Sample360 has conquered the UK. First, it is an independent
provider, making it quite unique. Secondly, the cloud-based app is mobile for use in all
sorts of settings, from hospitals to patients’ homes.
“We are truly independent of lab and hospital systems because we run a standards-
based communication protocol using HL7 (for standardized medical data transfer),”
McAlister explains. “We offer much more than big lab systems. In a mini-tender with UK
clinicians, we scored 95%; they scored 40% because they were missing parts like off-
site surgeries.”
Sample360’s performance has opened new markets, like the United Arab Emirates, and
created opportunities, such as animal husbandry.
“There are spinoffs—we could end up in the veterinary world because we know there
are high-value assets worth tracking. For example, we had a party wanting to track bull
semen because it’s worth an absolute fortune and is transported globally.”